Care pathways for the selection of a biologic in severe asthma
Care pathways for the selection of a biologic in severe asthma
Physicians need care pathways to select a biologic in type 2 severe asthma (omalizumab, mepolizumab, reslizumab) http://ow.ly/pygw30gB7Bv
Bousquet, Jean
8065d130-faa7-4c8e-bf40-8d2899980c21
Brusselle, Guy
7b8ee2aa-06d6-437c-8591-b09be09fed7b
Buhl, Roland
05200fd4-c811-4bdc-8474-8ac835a0292b
Busse, William W.
ce4badff-37c5-43ca-a199-dd130d929932
Cruz, Alvaro A.
35c073a4-664c-42b0-9705-f3416d5f8ade
Djukanovic, Ratko
d9a45ee7-6a80-4d84-a0ed-10962660a98d
Domingo, Christian
4a8cd04f-d99e-4546-9530-c2e318fb3aee
Hanania, Nicola A.
3dc51be1-4634-4d14-a27b-cd2ad16c57fe
Humbert, Marc
4810a9ae-540b-4b74-a72e-df68dbea47d3
Menzies-Gow, Andrew
ea52b653-05af-4cb6-addd-1bc9eb270abe
Phipatanakul, Wanda
f89a39f9-77b7-4ceb-8bc1-57d9eea2886b
Wahn, Ulrich
902b5866-4133-4792-93e6-27c4d9dc9f1f
Wechsler, Michael E.
1e584923-ffac-483b-9e81-30a666d44b9f
Bousquet, Jean
8065d130-faa7-4c8e-bf40-8d2899980c21
Brusselle, Guy
7b8ee2aa-06d6-437c-8591-b09be09fed7b
Buhl, Roland
05200fd4-c811-4bdc-8474-8ac835a0292b
Busse, William W.
ce4badff-37c5-43ca-a199-dd130d929932
Cruz, Alvaro A.
35c073a4-664c-42b0-9705-f3416d5f8ade
Djukanovic, Ratko
d9a45ee7-6a80-4d84-a0ed-10962660a98d
Domingo, Christian
4a8cd04f-d99e-4546-9530-c2e318fb3aee
Hanania, Nicola A.
3dc51be1-4634-4d14-a27b-cd2ad16c57fe
Humbert, Marc
4810a9ae-540b-4b74-a72e-df68dbea47d3
Menzies-Gow, Andrew
ea52b653-05af-4cb6-addd-1bc9eb270abe
Phipatanakul, Wanda
f89a39f9-77b7-4ceb-8bc1-57d9eea2886b
Wahn, Ulrich
902b5866-4133-4792-93e6-27c4d9dc9f1f
Wechsler, Michael E.
1e584923-ffac-483b-9e81-30a666d44b9f
Bousquet, Jean, Brusselle, Guy, Buhl, Roland, Busse, William W., Cruz, Alvaro A., Djukanovic, Ratko, Domingo, Christian, Hanania, Nicola A., Humbert, Marc, Menzies-Gow, Andrew, Phipatanakul, Wanda, Wahn, Ulrich and Wechsler, Michael E.
(2017)
Care pathways for the selection of a biologic in severe asthma.
European Respiratory Journal, 50 (6).
(doi:10.1183/13993003.01782-2017).
Abstract
Physicians need care pathways to select a biologic in type 2 severe asthma (omalizumab, mepolizumab, reslizumab) http://ow.ly/pygw30gB7Bv
Text
14-12-2017
- Version of Record
Restricted to Repository staff only
Request a copy
More information
Accepted/In Press date: 3 October 2017
e-pub ahead of print date: 7 December 2017
Identifiers
Local EPrints ID: 418620
URI: http://eprints.soton.ac.uk/id/eprint/418620
ISSN: 0903-1936
PURE UUID: 105b1776-c28b-4f41-8f42-a5e6dc60e34d
Catalogue record
Date deposited: 12 Mar 2018 17:31
Last modified: 16 Mar 2024 02:36
Export record
Altmetrics
Contributors
Author:
Jean Bousquet
Author:
Guy Brusselle
Author:
Roland Buhl
Author:
William W. Busse
Author:
Alvaro A. Cruz
Author:
Christian Domingo
Author:
Nicola A. Hanania
Author:
Marc Humbert
Author:
Andrew Menzies-Gow
Author:
Wanda Phipatanakul
Author:
Ulrich Wahn
Author:
Michael E. Wechsler
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
